GlassScriptPhysician profile
Charles A Safely
NPI 1962468835
$2,861.59
in general payments reported to CMS, 2019-2025
31 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $952 · 2020: $253 · 2021: $586 · 2022: $445 · 2023: $268 · 2024: $137 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $800.00 | 2019 | |
| Abbvie INC. | $483.77 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Millicent US INC | $370.82 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $177.08 | 2022-2023 | |
| Intuitive Surgical, INC. | $128.03 | 2025 | |
| Orexo US, INC. | $117.53 | 2023-2025 | Zubsolv |
| Virtus Pharmaceuticals LLC | $110.64 | 2021-2022 | |
| Exeltis, USA INC. | $99.79 | 2020-2023 | Slynd |
| Sumitomo Pharma America, INC. | $71.99 | 2023-2024 | Myfembree |
| Aspira Women'S Health INC | $44.61 | 2022 | |
| Therapeuticsmd, INC. | $43.93 | 2019-2021 | |
| Heron Therapeutics, INC. | $39.15 | 2025 | Zynrelef |
| Astellas Pharma US INC | $35.70 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $25.95 | 2021 | |
| Caldera Medical, INC | $24.07 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.04 | 2022 | |
| Baxter Healthcare | $23.31 | 2020 | |
| Covidien LP | $23.12 | 2019 | |
| Olympus America INC. | $21.28 | 2019 | |
| Pfizer INC. | $21.19 | 2023 | |
| Biogen, INC. | $20.55 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $20.20 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.28 | 2022 | |
| Vertical Pharmaceuticals, LLC | $18.24 | 2019 | |
| Lsi Solutions INC | $17.71 | 2019 | |
| Agile Therapeutics, INC. | $15.86 | 2022 | |
| Organon LLC | $13.82 | 2025 | Nexplanon |
| Avion Pharmaceuticals | $13.45 | 2022 | |
| Coloplast Corp | $12.90 | 2021 | |
| Allergan, INC. | $12.89 | 2020 | |
| Minerva Surgical, INC | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Safely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.